Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muriel Cuendet

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Chimia|August 8, 2012
Plants as a source of therapeutic and health productsPhilippe Christen, Muriel Cuendet
Molecular Biology Reports|May 25, 2023
Resveratrol as a circadian clock modulator: mechanisms of action and therapeutic applicationsWeronika Spaleniak, Muriel Cuendet
Medchemcomm|August 16, 2018
Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cellsMark E Issa, Muriel Cuendet
Journal of Natural Products|February 28, 2004
Antitumor activity of bruceantin: an old drug with new promiseMuriel Cuendet, John M Pezzuto
Chemico-Biological Interactions|May 30, 2006
Response of human mammary epithelial cells to DNA damage induced by 4-hydroxyequilenin: Lack of p53-mediated G1 arrestMuriel Cuendet, Judy L Bolton
Planta Medica|May 5, 2017
Targeting Multiple Myeloma Cancer Stem Cells with Natural Products - Lessons from Other Hematological MalignanciesMark E Issa, Sylvian Cretton, Muriel Cuendet
Journal of Enzyme Inhibition and Medicinal Chemistry|May 6, 2016
Cell-based multi-substrate assay coupled to UHPLC-ESI-MS/MS for a quick identification of class-specific HDAC inhibitorsVincent Zwick, Claudia Simões-Pires, Muriel Cuendet
Expert Opinion on Therapeutic Patents|April 20, 2018
HDAC inhibitors: a 2013-2017 patent surveyMicaela Faria Freitas, Muriel Cuendet, Philippe Bertrand
Cancers|May 28, 2022
The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAsIsabel F Coira, Rafael Rincón, Muriel Cuendet
Cancer Letters|March 17, 2004
Brusatol-induced HL-60 cell differentiation involves NF-kappaB activationMuriel Cuendet, Joell J Gills, John M Pezzuto
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Chimia|August 8, 2012
Plants as a source of therapeutic and health productsPhilippe Christen, Muriel Cuendet
Molecular Biology Reports|May 25, 2023
Resveratrol as a circadian clock modulator: mechanisms of action and therapeutic applicationsWeronika Spaleniak, Muriel Cuendet
Medchemcomm|August 16, 2018
Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cellsMark E Issa, Muriel Cuendet
Journal of Natural Products|February 28, 2004
Antitumor activity of bruceantin: an old drug with new promiseMuriel Cuendet, John M Pezzuto
Chemico-Biological Interactions|May 30, 2006
Response of human mammary epithelial cells to DNA damage induced by 4-hydroxyequilenin: Lack of p53-mediated G1 arrestMuriel Cuendet, Judy L Bolton
Planta Medica|May 5, 2017
Targeting Multiple Myeloma Cancer Stem Cells with Natural Products - Lessons from Other Hematological MalignanciesMark E Issa, Sylvian Cretton, Muriel Cuendet
Journal of Enzyme Inhibition and Medicinal Chemistry|May 6, 2016
Cell-based multi-substrate assay coupled to UHPLC-ESI-MS/MS for a quick identification of class-specific HDAC inhibitorsVincent Zwick, Claudia Simões-Pires, Muriel Cuendet
Expert Opinion on Therapeutic Patents|April 20, 2018
HDAC inhibitors: a 2013-2017 patent surveyMicaela Faria Freitas, Muriel Cuendet, Philippe Bertrand
Cancers|May 28, 2022
The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAsIsabel F Coira, Rafael Rincón, Muriel Cuendet
Cancer Letters|March 17, 2004
Brusatol-induced HL-60 cell differentiation involves NF-kappaB activationMuriel Cuendet, Joell J Gills, John M Pezzuto
Pageof 10